Bayer and National Hospital Of Obstetrics And Gynecology Announce Strategic Partnership for 2026-2028 to Advance Women’s Healthcare in Vietnam

  • Innovation

HANOI, Vietnam – May 08, 2026 – Bayer Vietnam and the National Hospital of Obstetrics and Gynecology (NHOG) have officially signed a Memorandum of Understanding (MoU) for a new strategic partnership spanning 2026-2028. This agreement marks a significant milestone in their long-standing collaboration, aimed at elevating the quality of care and expanding access to advanced therapeutic solutions for women across Vietnam. Building upon the successful outcomes of the 2023-2025 period, this new phase signifies a strategic evolution from foundational medical education to deep clinical integration and comprehensive healthcare innovation.

Bayer Vietnam and the National Hospital of Obstetrics and Gynecology (NHOG) formalize their 2026–2028 strategic partnership through the signing of a Memorandum of Understanding.

Bayer Vietnam and the National Hospital of Obstetrics and Gynecology (NHOG) formalize their 2026–2028 strategic partnership through the signing of a Memorandum of Understanding.

The 2026-2028 MoU reflects a shared vision to address the increasingly diverse and complex clinical needs of Vietnamese women throughout their life stages. While continuing to strengthen initiatives in hormonal contraception, family planning, endometriosis management, and heavy menstrual bleeding treatment, the partnership will expand its focus into critical new frontiers. These include improving maternal health through specialized nutrition and gestational hypertension management, as well as addressing modern gynecological challenges such as vaginal infections and menopause management. By introducing innovative pharmaceuticals and sustainable self-care solutions, both parties aim to ensure a holistic and seamless healthcare journey for patients.

In line with the 2028 digital health vision, Bayer Vietnam and NHOG are committed to accelerating digital transformation and international connectivity. The collaboration will prioritize the implementation of telehealth platforms to bridge the gap in access to high-quality medical services, alongside international expert exchange programs to ensure local medical staff stay at the forefront of global clinical guidelines. Beyond capacity building, the partnership will focus on generating essential medical data through clinical research and developing standardized guidelines to improve the quality of women's healthcare on a national scale.

Commenting on this strategic partnership, Mr. James Alexander, Country Division Head of Pharmaceuticals at Bayer Vietnam, stated: " At Bayer, women’s healthcare extends far beyond clinical treatment; it is a lifelong commitment to accompanying women through every critical stage of their lives. We are profoundly honored to continue our partnership with the National Hospital of Obstetrics and Gynecology, a cornerstone of maternal and reproductive health in Vietnam. This collaboration is deeply meaningful, as it allows us to synergize Bayer’s global medical innovations with the Hospital’s exceptional clinical expertise to realize our shared vision. Furthermore, Bayer is actively accelerating the introduction of world-class pharmaceutical solutions to the Vietnamese market. Our goal is to empower healthcare professionals with a broader range of safe and effective treatment options, ultimately enhancing the quality of life and well-being for women across the country throughout their health journey.”

Representatives from Bayer Vietnam and the National Hospital of Obstetrics and Gynecology discuss collaboration priorities aimed at improving women’s healthcare in Vietnam.

Echoing this sentiment, Prof. Dr. Nguyen Duy Anh, Director of the National Hospital of Obstetrics and Gynecology, emphasized that this strategic alignment provides the necessary resources to bridge the gap between scientific advancement and community awareness, ensuring that every woman in Vietnam could access modern, professional medical consultancy and life-changing treatments.

The signing of this Memorandum of Understanding reaffirms the long-term commitment of Bayer Vietnam and the National Hospital of Obstetrics and Gynecology to strengthening the national healthcare system. By fostering scientific innovation and continuously improving care standards, both organizations are working together to build a future where Vietnamese women can enjoy a healthier, more vibrant quality of life through world-class medical excellence.